Exchange: An ETF Experience An ETF Nerd’s Exchange Conference Preview By Todd RosenbluthJanuary 16, 2024
Expert Insights This Week in ETFs: Invesco Makes Changes to 35 Funds By Heather BellSeptember 1, 2023
Innovative ETFs Content Hub Invesco’s Rene Reyna on Biotech’s Rally and the Potential for Future Growth By Elle Caruso FitzgeraldAugust 19, 2022
Featured Biotech ETFs Are Already Benefitting from Pfizer Vaccine’s Full Approval By Ian YoungAugust 23, 2021
Innovative ETFs Content Hub Will Biotech ETFs Benefit from Biogen’s New Alzheimer’s Drug? By Ian YoungJune 9, 2021
ETF Education Content Hub Biopharma Here to Stay: The Long-Term Case for the PBE ETF By Tom LydonJanuary 20, 2021
Thematic Investing Content Hub Thematic ETF Asset Growth Climbs Even Higher By Todd RosenbluthOctober 7, 2020
Equity ETFs M&A Activity, Passing Drug Trials Help Biotech ETFs Rebound By Max ChenSeptember 12, 2016
